Midas Pharmaceuticals Inc is categorized under Wholesale Pharmaceutical Products in Parsippany, NJ and active since 2001.
Midas Pharmaceuticals Inc was established in 2001, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number by the NAICS.
If you are seeking more information, feel free to contact Tim Feuerstein, Other at the company’s single location by writing to 300 Interpace Parkway # 440, Parsippany, New Jersey NJ 07054 or by phoning (973) 541-4911. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Midas Pharmaceuticals Inc |
| Contact Person: | Tim Feuerstein, Other |
| Address: | 300 Interpace Parkway # 440, Parsippany, New Jersey 07054 |
| Phone Number: | (973) 541-4911 |
| Annual Revenue (USD): | $10.000.000 to $19.9999.999 |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Wholesale Pharmaceutical Products |
| Share This Business: |
Midas Pharmaceuticals Inc was started in 2001 to provide professional Wholesale Pharmaceutical Products under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.
Feel free to contact Tim Feuerstein, Other for inquiries that concern Midas Pharmaceuticals Inc by calling the company number (973) 541-4911, as your correspondence is most welcome. Additionally, the physical location of the single location of Midas Pharmaceuticals Inc can be found at the coordinates as well as the street address 300 Interpace Parkway # 440 in Parsippany, New Jersey 07054.
For its online presence, you may visit Midas Pharmaceuticals Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.